Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C5H9O2.Zn |
| Molecular Weight | 267.657 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Zn++].CCCCC([O-])=O.CCCCC([O-])=O
InChI
InChIKey=BUDAIZWUWHWZPQ-UHFFFAOYSA-L
InChI=1S/2C5H10O2.Zn/c2*1-2-3-4-5(6)7;/h2*2-4H2,1H3,(H,6,7);/q;;+2/p-2
| Molecular Formula | C5H9O2 |
| Molecular Weight | 101.1238 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Zn |
| Molecular Weight | 65.409 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Valeric acid is a colorless, oily liquid with an unpleasant odor. It is highly corrosive and must be handled with care. Valeric acid is mainly used as a chemical intermediate to manufacture flavors and perfumes, synthetic lubricants, agricultural chemicals, and pharmaceuticals. It is also used as a flavoring aid in foods. Valeric acid is considered safe as a food additive by the World Health Organization.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Percutaneous absorption of diflucortolone valerate in guinea pigs and man (author's transl)]. | 1976 |
|
| Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil. | 2001 |
|
| Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease. | 2001 Dec 14 |
|
| Effect of ruminal vs postruminal administration of degradable protein on utilization of low-quality forage by beef steers. | 2001 Jan |
|
| Biotin reagents for antibody pretargeting. 5. Additional studies of biotin conjugate design to provide biotinidase stability. | 2001 Jul-Aug |
|
| Significance of substrate hydrophobicity for recognition by an oligopeptide transporter (PEPT1). | 2001 Jul-Aug |
|
| Aroma-active components of nonfat dry milk. | 2001 Jun |
|
| Production of poly(3-hydroxybutyrateco-3-hydroxyvalerate) from cottonseed oil and valeric acid in batch culture of Raistonia sp. strain JC-64. | 2001 May |
|
| [High-level production of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) by feb-batch culture of Alcaligenes eutrophus]. | 2001 Sep |
|
| Estradiol valerate/dienogest. | 2002 |
|
| Effect of casein infusion in the rumen, duodenum or both sites on factors affecting forage intake and performance of dairy cows fed red clover-grass silage. | 2002 Apr |
|
| Comparative study of differentiation levels and valepotriate content of in vitro cultures and regenerated and wild plants of Valeriana edulis ssp.procera. | 2002 Apr |
|
| Influence of yeast culture on ruminal microbial metabolism in continuous culture. | 2002 Aug |
|
| Sensitization of trigeminal caudalis neuronal responses to intraoral acid and salt stimuli and desensitization by nicotine. | 2002 Aug |
|
| Carvacrol and thymol reduce swine waste odor and pathogens: stability of oils. | 2002 Jan |
|
| Thermal degradation of poly(3-hydroxyalkanoates): preparation of well-defined oligomers. | 2002 Jan-Feb |
|
| Metabolic characteristics of the faecal microflora in humans from three age groups. | 2002 Jul |
|
| Development of a headspace solid-phase microextraction-gas chromatography-mass spectrometry method for the identification of odour-causing volatile compounds in packaging materials. | 2002 Jul 19 |
|
| 1H and (13)C NMR spectroscopic analysis of human saliva. | 2002 Jun |
|
| A rapid selective extraction procedure for the outer membrane protein (OmpF) from Escherichia coli. | 2002 Jun |
|
| Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. | 2002 Jun |
|
| In vitro alterations in fecal short chain fatty acids and organic anions induced by the destruction of intestinal microflora under hypotonic and aerobic conditions. | 2002 Jun |
|
| Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle. | 2002 Mar |
|
| Structural characterization of in vivo rat glutathione adducts and a hydroxylated metabolite of simvastatin hydroxy acid. | 2002 Mar |
|
| Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients. | 2002 Nov 20 |
|
| Enhancement of NGF- and cholera toxin-induced neurite outgrowth by butyrate in PC12 cells. | 2002 Oct 4 |
|
| Production of specific copolymers of polyhydroxyalkanoates from industrial waste. | 2002 Spring |
|
| Psychophysical evaluation of responses to pleasant and mal-odour stimulation in human subjects; adaptation, dose response and gender differences. | 2003 Apr |
|
| Effects of hydrochloric, valeric, and other volatile fatty acids on pathogenesis of ulcers in the nonglandular portion of the stomach of horses. | 2003 Apr |
|
| Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. | 2003 Apr |
|
| Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. | 2003 Apr 18 |
|
| Parameter identification of thermophilic anaerobic degradation of valerate. | 2003 Apr-Jun |
|
| Conformationally constrained analogues of bleomycin A5. | 2003 Aug 27 |
|
| Eubacterium pyruvativorans sp. nov., a novel non-saccharolytic anaerobe from the rumen that ferments pyruvate and amino acids, forms caproate and utilizes acetate and propionate. | 2003 Jul |
|
| Dynamics of the anaerobic process: effects of volatile fatty acids. | 2003 Jun 30 |
|
| Improvement of (+)-catechin inhibitory activity on human PMN respiratory burst by (+)-3-O-propionyl and (-)-3-O-valeryl substitution. | 2003 Mar |
|
| Lack of quinine-evoked activity in rat trigeminal subnucleus caudalis. | 2003 Mar |
|
| Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: role of hepatic nuclear factor-4alpha. | 2003 Oct 17 |
|
| Synthesis, X-ray crystal structure, UV/visible linear and nonlinear (optical limiting) spectral properties of symmetrical and unsymmetrical porphyrazines with annulated 1,2,5-thiadiazole and 1,4-diamyloxybenzene moieties. | 2003 Sep 5 |
|
| The degradability of biodegradable plastics in aerobic and anaerobic waste landfill model reactors. | 2004 Jan |
|
| Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. | 2004 Jan 27 |
|
| Sequential feeding of glucose and valerate in a fed-batch culture of Ralstonia eutropha for production of poly(hydroxybutyrate-co-hydroxyvalerate) with high 3-hydroxyvalerate fraction. | 2004 Jan-Feb |
|
| Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. | 2004 Mar |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:02:33 GMT 2023
by
admin
on
Fri Dec 15 16:02:33 GMT 2023
|
| Record UNII |
HHJ036TQR0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
209-124-1
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | |||
|
68393
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | |||
|
1546360
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID00890509
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | |||
|
m11634
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | Merck Index | ||
|
HHJ036TQR0
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | |||
|
556-38-7
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | |||
|
100000145791
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | |||
|
HHJ036TQR0
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY | |||
|
SUB124575
Created by
admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |